Idamycin PFS® (idarubicin hydrochloride injection)

1 mg/mL

10 mg/10 mL

Onco-Tain™ Single Dose Glass Fliptop Vial

Unit of Sale NDC: 00013-2586-10

Available
To set product alerts you must or register

Cap color: Purple

Product insert Safety data sheet
Wholesalers
Cardinal 5911326
Cencora 10287686
McKesson 2920536
Morris & Dickson 359661
Ordering information
Unit of Sale size 1
Case size 1 x 112
Cases per pallet 60
Unit of Sale dimensions 1.560x1.560x3.170
Unit of Sale weight 0.072
Unit of Sale per shipper 112
Shipper outer dimensions 13.780x11.810x7.680
Shipper weight 9.152
Allergy information
Non-DEHP
Latex information
Preservative free
Gluten free
Availability specifics
Additional information View

If Latex Information is present above, then natural rubber latex has not been used in the manufacturing of this device or drug container closure system.

If Preservative Free is present above, then this product does not contain ingredients identified as a preservative, as defined by the USP.

Cap color: Purple

Unit of Sale NDC:00013-2586-10

Idamycin PFS® (idarubicin hydrochloride injection)

Unit of Sale NDC:
00013-2586-10

Unit of Use NDC:00013-2586-10

Idamycin PFS® (idarubicin hydrochloride injection)

Unit of Use NDC:
00013-2586-10

Additional family SKUs (5)

Available
To set product alerts you must or register

Idamycin PFS® (idarubicin hydrochloride injection)

5mg/5ml

Onco-Tain™ Single Dose Glass Fliptop Vial

UoS NDC: 00013-2576-05
Available
To set product alerts you must or register

Idamycin PFS® (idarubicin hydrochloride injection)

20 mg/20 mL

Onco-Tain™ Single Dose Glass Fliptop Vial

UoS NDC: 00013-2596-20
Depleted
To set product alerts you must or register

Idamycin PFS® (idarubicin hydrochloride injection)

20 mg/20 mL

CYTOSAFE® Single-use Vial

UoS NDC: 00013-2596-91
Depleted
To set product alerts you must or register

Idamycin PFS® (idarubicin hydrochloride injection)

5 mg/5 mL

CYTOSAFE® Single-use Vial

UoS NDC: 00013-2576-91
Depleted
To set product alerts you must or register

Idamycin PFS® (idarubicin hydrochloride injection)

10 mg/10 mL

CYTOSAFE® Single-use Vial

UoS NDC: 00013-2586-91

Related news

Product Updates

Product NDC Change: Fluconazole in Sodium Chloride Injection, USP 400 mg/200 mL (2 mg/mL) Flexible Container

Product Updates

Product NDC Change: Fluconazole in Sodium Chloride Injection, USP 200 mg/100 mL (2 mg/mL) Flexible Container

Product Updates

Product NDC and Pack Size Change: Marcaine® 0.5% (bupivacaine hydrochloride injection, USP) 50 mg/10 mL (5 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC Change: Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC Change: Midazolam Injection, USP CIV 2 mg/2 mL (1 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change for Metoclopramide Injection, USP 10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change for DOXOrubicin Hydrochloride Injection, USP, Multiple Presentations

Product Updates

Product NDC Change for Idamycin PFS® (idarubicin hydrochloride injection) 5 mg/5 mL (1 mg/mL) Single Dose Vial

Product Updates

Product NDC and Vial Presentation Change for Camptosar® (Irinotecan Hydrochloride Injection, USP) 300 mg/15 mL (20 mg/mL) Single Dose Vial

Product Updates

NDC and Formulation Change for Levofloxacin in 5% Dextrose Injection Flexible Container Presentations

Product Updates

NDC Change for Idamycin PFS® (idarubicin hydrochloride injection), 10 mg/10 mL (1 mg/mL) Single Dose Vial

Product Updates

NDC Change for Idamycin PFS® (idarubicin hydrochloride injection), 20 mg/20 mL

Recalls Withdrawals or Important Safety Information

Urgent Recall: Bleomycin for Injection, USP, 15 Units Single-Dose ONCO-TAIN™ Glass Fliptop Vial

Product Updates

NDC and Packaging Change for Labetalol Hydrochloride Injection, USP 100 mg/20 mL (5 mg/mL) Multiple-dose Vial

Product Updates

NDC and Labeling Change: Rocuronium Bromide NDC Labeling Change

Product Updates

NDC and Labeling Change Linezolid Injection in 0.9% Sodium Chloride 600 mg/300 mL (2 mg/mL) Single-dose Container

Product Updates

NDC and Labeling Change: Ciprofloxacin in 5% Dextrose Injection, USP 200 mg/100 mL (2 mg/mL) Single-Dose Flexible Container

Product Updates

NDC and Labeling Change for Magnesium Sulfate in Water for Injection 40 g/1000 mL (40 mg/mL) Single-Dose Flexible Container

Product Updates

Product NDC Change for Ciprofloxacin in 5% Dextrose Injection, USP 400 mg/200 mL (2 mg/mL) Single Dose Flexible Container

Product Updates

NDC and Packaging Update for Heparin Sodium in Sodium Chloride Injection Flexible Container, Multiple Presentations

Product Updates

NDC and Packaging Change for Heparin Sodium in 0.45% Sodium Chloride Injection, 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container

Product Updates

NDC and Packaging Update for Magnesium Sulfate in Water for Injection Flexible Container, Multiple Presentations

Product Updates

NDC and Packaging Change for Heparin Sodium in 0.45% Sodium Chloride Injection, 25,000 USP Units/500 mL (50 USP Units/mL) Flexible Container

Product Updates

NDC and Packaging Change for Heparin Sodium in 5% Dextrose Injection 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container